#Denmark #Water Technology #Kongens Lyngby #Aquaporin A/S #Aquaporin Inside

Aquaporin A/S Q3 2025 Trading Statement

In a significant update from Aquaporin A/S, an innovative water technology enterprise, the company has announced its trading statement for the third quarter of 2025, covering the period from January 1 to September 30, 2025. The findings indicate a surge in commercial traction during the third quarter, reinforcing the company’s commitment to redefining water filtration through biotechnology. Ulrik Lund Jakobsen, the Chief Executive Officer of Aquaporin, expressed optimism regarding their strategic direction, stating, "Our strong backlog for the remaining part of the year validates a clear path towards reaching the communicated revenue guidance. We are working diligently on the strategic review to raise capital and secure the financial position of the Company from 2026 onwards."

Financial Highlights

During the nine-month period, Aquaporin reported revenues of DKK 13.2 million, which indicates a reduction from DKK 32.8 million during the same timeframe in 2024. However, the third quarter alone posted revenues of DKK 4.1 million, showcasing a 14% increase compared to DKK 3.6 million in Q3 2024. Despite these gains, the EBITDA (excluding special items) reflected a loss of DKK 14.5 million for Q3 2025, slightly improving from a loss of DKK 16.0 million in the previous year.

By the end of September 2025, the company's cash and cash equivalents stood at DKK 8.8 million, a stark decline from DKK 93.1 million in September 2024. Consequently, Aquaporin adjusted its revenue forecast for 2025 to a range of DKK 40-50 million, down from an initial estimate of DKK 60-80 million, while maintaining its EBITDA loss forecast between DKK 45 million and DKK 55 million.

Business Developments

Aquaporin marked notable milestones in its operations over recent months. In August, the company announced a successful trial milestone with Singapore's National Water Agency, PUB, demonstrating that its biomimetic membranes achieved energy savings of up to 20%. Additionally, in May, Aquaporin secured a pilot plant contract to supply a Forward Osmosis system for Trinity College Dublin, joining a research initiative aimed at recovering bio-based products. Aquaporin has also engaged in collaborative efforts with the Danish Water Alliance China, exploring avenues for improving wastewater management in the region.

Looking ahead, Aquaporin is actively engaged in strategic planning to secure adequate capital for operational stability beyond 2025. The company outlined its intention to raise gross proceeds between DKK 125 million and DKK 175 million to align with its growth objectives and restore its financial health. This review is critical for accommodating the potential outcomes of transactions pertaining to future funding.

Moreover, Aquaporin convened an extraordinary general meeting scheduled for December 1, 2025, to address the need for flexibility in their strategic planning. Discussions with a mix of existing shareholders and prospective investors are ongoing, aimed at identifying feasible financing options.

Conclusion

Aquaporin A/S illustrates both resilience and strategic foresight in an evolving water technology landscape. The third-quarter performance reflects a blend of optimism and caution, as the company aims to capitalize on its advancements in technology while navigating financial challenges. The coming months will be crucial as initiatives to raise the requisite capital unfold, with the potential to affect the company's trajectory positively.

As Aquaporin continues to build partnerships globally, the focus remains on delivering innovative solutions that meet diverse water needs. By weaving together biology, chemistry, and physics, the company is committed to pioneering sustainable water management practices that could alleviate global water challenges.

For further details, please contact Ulrik Lund Jakobsen or Klaus Juhl Wulff, who are eager to share Aquaporin's journey towards sustainability and innovation.